nach oben

Familial Cancer

Erschienen in:

01.06.2013 | Original Article

100 years lynch syndrome: what have we learned about psychosocial issues?

verfasst von: Eveline M. A. Bleiker, Mary Jane Esplen, Bettina Meiser, Helle Vendel Petersen, Andrea Farkas Patenaude

Erschienen in: Familial Cancer | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

In the care of patients with Lynch Syndrome (LS), a range of psychosocial issues are encountered, which significantly affect patient outcomes. A brief historical background of ‘psycho-onco-genetics’ (the domain where psychology, oncology and genetics meet) in relation to LS is presented, followed by an overview of important psychosocial issues identified in the past 20 years. The identification of mismatch repair genes in 1993–1994 made possible genetic counseling and testing for patients who had cancer and for potentially high-risk relatives without cancer. At that time, concerns were raised about the potentially negative psychosocial impact of predictive genetic testing. Since 1993, a large number of studies have been conducted to investigate the possible psychosocial benefits and limitations of such testing. This article presents an overview of: the uptake of and motivations for genetic testing, its psychosocial impact (e.g. psychological adaptation, impact on risk perception and self-concept, and concerns about, and experiences of, genetic discrimination), psychological screening instruments, adherence to and decision-making about preventive strategies, family communication, lifestyle changes, reproductive technology utilization, and professional psychosocial support needs of members of families with LS. Finally, challenges for the future are discussed, including population screening and genomic testing.

Vasen HF, Blanco I, Aktan-Collan K, Gopie JP, Alonso A, Aretz S, Bernstein I, Bertario L, Burn J, Capella G, Colas C, Engel C, Frayling IM, Genuardi M, Heinimann K, Hes FJ, Hodgson SV, Karagiannis JA, Lalloo F, Lindblom A, Mecklin JP, Moller P, Myrhoj T, Nagengast FM, Parc Y, Ponz de Leon M, Renkonen-Sinisalo L, Sampson JR, Stormorken A, Sijmons RH, Tejpar S, Thomas HJ, Rahner N, Wijnen JT, Jarvinen HJ, Moslein G (2013) Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut 62(6):812–823. doi:10.1136/gutjnl-2012-304356

Lynch HT, Lynch PM, Lanspa SJ, Snyder CL, Lynch JF, Boland CR (2009) Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet 76:1–18PubMedCrossRef

Engel C, Loeffler M, Steinke V, Rahner N, Holinski-Feder E, Dietmaier W, Schackert HK, Goergens H, Knebel Doeberitz M, Goecke TO, Schmiegel W, Buettner R, Moeslein G, Letteboer TG, Garcia EG, Hes FJ, Hoogerbrugge N, Menko FH, van Os TA, Sijmons RH, Wagner A, Kluijt I, Propping P, Vasen HF (2012) Risks of less common cancers in proven mutation carriers with lynch syndrome. J Clin Oncol 30:4409–4415PubMedCrossRef

Lynch HT, de la Chapelle A (2003) Hereditary colorectal cancer. N Engl J Med 348:919–932PubMedCrossRef

Renkonen-Sinisalo L, Aarnio M, Mecklin JP, Jarvinen HJ (2000) Surveillance improves survival of colorectal cancer in patients with hereditary nonpolyposis colorectal cancer. Cancer Detect Prev 24:137–142PubMed

Syngal S, Weeks JC, Schrag D, Garber JE, Kuntz KM (1998) Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations. Ann Intern Med 129:787–796PubMedCrossRef

Jarvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomaki P, de la Chapelle A, Mecklin JP (2000) Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118:829–834PubMedCrossRef

Holland JC (2002) History of psycho-oncology: overcoming attitudinal and conceptual barriers. Psychosom Med 64:206–221PubMed

Sutherland AM, Orbach CE, Dyk RB, Bard M (1952) The psychological impact of cancer and cancer surgery. I. Adaptation to the dry colostomy; preliminary report and summary of findings. Cancer 5:857–872PubMedCrossRef

10.

Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376PubMedCrossRef

11.

Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11:570–579PubMed

12.

Bultz BD, Johansen C (2011) Screening for distress, the 6th vital sign: where are we, and where are we going? Psychooncology 20:569–571PubMedCrossRef

13.

Warthin A (1985) Classics in oncology. Heredity with reference to carcinoma as shown by the study oh the cases examined in the pathological laboratory of the University of Michigan, 1895–1913. By Aldred Scott Warthin. CA Cancer J Clin 35:348–359CrossRef

14.

Lynch HT, Krush AJ (1968) Genetic counseling and cancer: implications for cancer control. South Med J 61:265–269PubMedCrossRef

15.

Krush AJ, Lynch HT, Magnuson C (1965) Attitudes toward Cancer in a “Cancer family”: implications for cancer detection. Am J Med Sci 249:432–438PubMedCrossRef

16.

Lerman C, Lustbader E, Rimer B, Daly M, Miller S, Sands C, Balshem A (1995) Effects of individualized breast cancer risk counseling: a randomized trial. J Natl Cancer Inst 87:286–292PubMedCrossRef

17.

Lerman C, Daly M, Masny A, Balshem A (1994) Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 12:843–850PubMed

18.

Jarvinen HJ, Renkonen-Sinisalo L, Aktan-Collan K, Peltomaki P, Aaltonen LA, Mecklin JP (2009) Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members. J Clin Oncol 27:4793–4797PubMedCrossRef

19.

Jarvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomaki P, Mecklin JP (2000) Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118:829–834PubMedCrossRef

20.

21.

Vasen HF, Abdirahman M, Brohet R, Langers AM, Kleibeuker JH, van Kouwen M, Koornstra JJ, Boot H, Cats A, Dekker E, Sanduleanu S, Poley JW, Hardwick JC, de Vos Tot Nederveen Cappel WH, van der Meulen-de Jong AE, Tan TG, Jacobs MA, Mohamed FL, de Boer SY, van de Meeberg PC, Verhulst ML, Salemans JM, van Bentem N, Westerveld BD, Vecht J, Nagengast FM (2010) One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome. Gastroenterology 138:2300–2306PubMedCrossRef

22.

de Vos tot Nederveen Cappel WH, Jarvinen HJ, Lynch PM, Engel C, Mecklin JP, Vasen HFA (2013) Colorectal surveillance in Lynch syndrome families. Fam Cancer. doi:10.1007/s10689-013-9631-1

23.

de Jong AE, Hendriks YM, Kleibeuker JH, de Boer SY, Cats A, Griffioen G, Nagengast FM, Nelis FG, Rookus MA, Vasen HF (2006) Decrease in mortality in Lynch syndrome families because of surveillance. Gastroenterology 130:665–671PubMedCrossRef

24.

Lerman C, Hughes C, Trock BJ, Myers RE, Main D, Bonney A, Abbaszadegan MR, Harty AE, Franklin BA, Lynch JF, Lynch HT (1999) Genetic testing in families with hereditary nonpolyposis colon cancer. JAMA 281:1618–1622PubMedCrossRef

25.

Hadley DW, Jenkins J, Dimond E, Nakahara K, Grogan L, Liewehr DJ, Steinberg SM, Kirsch I (2003) Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer. Arch Intern Med 163:573–582PubMedCrossRef

26.

Peterson SK, Watts BG, Koehly LM, Vernon SW, Baile WF, Kohlmann WK, Gritz ER (2003) How families communicate about HNPCC genetic testing: findings from a qualitative study. Am J Med Genet C Semin Med Genet 119:78–86CrossRef

27.

Keller M, Jost R, Kadmon M, Wullenweber HP, Haunstetter CM, Willeke F, Jung C, Gebert J, Sutter C, Herfarth C, Buchler MW (2004) Acceptance of and attitude toward genetic testing for hereditary nonpolyposis colorectal cancer: a comparison of participants and nonparticipants in genetic counseling. Dis Colon Rectum 47:153–162PubMedCrossRef

28.

Aktan-Collan K, Mecklin JP, Jarvinen H, Nystrom-Lahti M, Peltomaki P, Soderling I, Uutela A, de la Chapelle A, Kaariainen H (2000) Predictive genetic testing for hereditary non-polyposis colorectal cancer: uptake and long-term satisfaction. Int J Cancer 89:44–50PubMedCrossRef

29.

Aktan-Collan KI, Kaariainen HA, Kolttola EM, Pylvanainen K, Jarvinen HJ, Haukkala AH, Mecklin JP (2011) Sharing genetic risk with next generation: mutation-positive parents’ communication with their offspring in Lynch syndrome. Fam Cancer 10:43–50PubMedCrossRef

30.

Patenaude AF, Peterson SK (2010) Psychosocial issues in genetic testing for hereditary colorectal cancer. In: Holland JC, Breitbart WS, Jacobsen PB, Lederberg MS, Loscalzo MJ, McCorkle R (eds) Psycho-oncology. Oxford University Press, New York, pp 110–115CrossRef

31.

van Asperen CJ, Van Dijk S, Zoeteweij MW, Timmermans DR, de Bock GH, Meijers-Heijboer EJ, Niermeijer MF, Breuning MH, Kievit J, Otten W (2002) What do women really want to know? Motives for attending familial breast cancer clinics. J Med Genet 39:410–414PubMedCrossRef

32.

Shankar A, Chapman P, Goodship J (1999) Genetic counselling: do we recognise and meet the consultands’ agenda? J Med Genet 36:580–582PubMed

33.

Claes E, Denayer L, Evers-Kiebooms G, Boogaerts A, Legius E (2004) Predictive testing for hereditary non-polyposis colorectal cancer: motivation, illness representations and short-term psychological impact. Patient Educ Couns 55:265–274PubMedCrossRef

34.

Esplen MJ, Madlensky L, Butler K, McKinnon W, Bapat B, Wong J, Aronson M, Gallinger S (2001) Motivations and psychosocial impact of genetic testing for HNPCC. Am J Med Genet 103:9–15PubMedCrossRef

35.

Dewanwala A, Chittenden A, Rosenblatt M, Mercado R, Garber JE, Syngal S, Stoffel EM (2011) Attitudes toward childbearing and prenatal testing in individuals undergoing genetic testing for Lynch syndrome. Fam Cancer 10:549–556PubMedCrossRef

36.

Esplen MJ, Madlensky L, Aronson M, Rothenmund H, Gallinger S, Butler K, Toner B, Wong J, Manno M, McLaughlin J (2007) Colorectal cancer survivors undergoing genetic testing for hereditary non-polyposis colorectal cancer: motivational factors and psychosocial functioning. Clin Genet 72:394–401PubMedCrossRef

37.

Geer KP, Ropka ME, Cohn WF, Jones SM, Miesfeldt S (2001) Factors influencing patients’ decisions to decline cancer genetic counseling services. J Genet Couns 10:25–40PubMedCrossRef

38.

Hall MA, Rich SS (2000) Patients’ fear of genetic discrimination by health insurers: the impact of legal protections. Genet Med 2:214–221PubMedCrossRef

39.

Seppen J, Bruzzone L (2013) Lynch syndrome: the patients perspective. Fam Cancer. doi:10.1007/s10689-013-9630-2

40.

Hampel H (2010) Point: justification for Lynch syndrome screening among all patients with newly diagnosed colorectal cancer. J Natl Compr Canc Netw 8:597–601PubMed

41.

Vasen HF, Moslein G, Alonso A, Aretz S, Bernstein I, Bertario L, Blanco I, Bulow S, Burn J, Capella G, Colas C, Engel C, Frayling I, Rahner N, Hes FJ, Hodgson S, Mecklin JP, Moller P, Myrhoj T, Nagengast FM, Parc Y, Ponz de Leon M, Renkonen-Sinisalo L, Sampson JR, Stormorken A, Tejpar S, Thomas HJ, Wijnen J, Lubinski J, Jarvinen H, Claes E, Heinimann K, Karagiannis JA, Lindblom A, Dove-Edwin I, Muller H (2010) Recommendations to improve identification of hereditary and familial colorectal cancer in Europe. Fam Cancer 9:109–115PubMedCrossRef

42.

Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R, Hamilton SR, Hiatt RA, Jass J, Lindblom A, Lynch HT, Peltomaki P, Ramsey SD, Rodriguez-Bigas MA, Vasen HF, Hawk ET, Barrett JC, Freedman AN, Srivastava S (2004) Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96:261–268PubMedCrossRef

43.

Lindor NM, Petersen GM, Hadley DW, Kinney AY, Miesfeldt S, Lu KH, Lynch P, Burke W, Press N (2006) Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 296:1507–1517PubMedCrossRef

44.

Manne SL, Chung DC, Weinberg DS, Vig HS, Catts Z, Cabral MK, Shannon K, Meropol NJ (2007) Knowledge and attitudes about microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer. Cancer Epidemiol Biomarkers Prev 16:2110–2117PubMedCrossRef

45.

Landsbergen KM, Prins JB, Brunner HG, Hoogerbrugge N (2009) Genetic testing offered directly after the diagnosis of colorectal cancer: a pilot study on the reactions of patients. Genet Couns 20:317–325PubMed

46.

Landsbergen KM, Prins JB, Brunner HG, van Duijvendijk P, Nagengast FM, van Krieken JH, Ligtenberg M, Hoogerbrugge N (2012) Psychological distress in newly diagnosed colorectal cancer patients following microsatellite instability testing for Lynch syndrome on the pathologist’s initiative. Fam Cancer 11:259–267PubMedCrossRef

47.

Manne SL, Meropol NJ, Weinberg DS, Vig H, Ali-Khan Catts Z, Manning C, Ross E, Shannon K, Chung DC (2010) Facilitating informed decisions regarding microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer. J Clin Oncol 28:1366–1372PubMedCrossRef

48.

Hall MJ, Manne SL, Winkel G, Chung DS, Weinberg DS, Meropol NJ (2011) Effects of a decision support intervention on decisional conflict associated with microsatellite instability testing. Cancer Epidemiol Biomarkers Prev 20:249–254PubMedCrossRef

49.

Bleiker EMA, Menko FH, Kluijt I, Taal BG, Gerritsma MA, Wever LDV, Aaronson NK (2007) Colorectal cancer in the family: psychosocial distress and social issues in the years following genetic counseling. Hereditary Cancer Clin Pract 5:59–66CrossRef

50.

Gritz ER, Peterson SK, Vernon SW, Marani SK, Baile WF, Watts BG, Amos CI, Frazier ML, Lynch PM (2005) Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol 23:1902–1910PubMedCrossRef

51.

Bleiker EM, Menko FH, Taal BG, Kluijt I, Wever LD, Gerritsma MA, Vasen HF, Aaronson NK (2005) Screening behavior of individuals at high risk for colorectal cancer. Gastroenterology 128:280–287PubMedCrossRef

52.

Vernon SW, Gritz ER, Peterson SK, Amos CI, Perz CA, Baile WF, Lynch PM (1997) Correlates of psychologic distress in colorectal cancer patients undergoing genetic testing for hereditary colon cancer. Health Psychol 16:73–86PubMedCrossRef

53.

Esplen MJ, Urquhart C, Butler K, Gallinger S, Aronson M, Wong J (2003) The experience of loss and anticipation of distress in colorectal cancer patients undergoing genetic testing. J Psychosom Res 55:427–435PubMedCrossRef

54.

Bleiker EM, Menko FH, Taal BG, Kluijt I, Wever LD, Gerritsma MA, Vasen HF, Aaronson NK (2003) Experience of discharge from colonoscopy of mutation negative HNPCC family members. J Med Genet 40:e55PubMedCrossRef

55.

Collins V, Halliday J, Warren R, Williamson R (2000) Cancer worries, risk perceptions and associations with interest in DNA testing and clinic satisfaction in a familial colorectal cancer clinic. Clin Genet 58:460–468PubMedCrossRef

56.

DudokdeWit AC, Tibben A, Frets PG, Meijers-Heijboer EJ, Devilee P, Klijn JG, Oosterwijk JC, Niermeijer MF (1997) BRCA1 in the family: a case description of the psychological implications. Am J Med Genet 71:63–71PubMedCrossRef

57.

Codori AM, Waldeck T, Petersen GM, Miglioretti D, Trimbath JD, Tillery MA (2005) Genetic counseling outcomes: perceived risk and distress after counseling for hereditary colorectal cancer. J Genet Couns 14:119–132PubMedCrossRef

58.

Murakami Y, Okamura H, Sugano K, Yoshida T, Kazuma K, Akechi T, Uchitomi Y (2004) Psychologic distress after disclosure of genetic test results regarding hereditary nonpolyposis colorectal carcinoma. Cancer 101:395–403PubMedCrossRef

59.

van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, Brocker-Vriends AH, van Asperen CJ, Sijmons RH, Seynaeve C, van Gool AR, Klijn JG, Tibben A (2006) Experience of parental cancer in childhood is a risk factor for psychological distress during genetic cancer susceptibility testing. Ann Oncol 17:1090–1095PubMedCrossRef

60.

Keller M, Jost R, Haunstetter CM, Kienle P, Knaebel HP, Gebert J, Sutter C, Knebel-Doeberitz M, Cremer F, Mazitschek U (2002) Comprehensive genetic counseling for families at risk for HNPCC: impact on distress and perceptions. Genet Test 6:291–302PubMedCrossRef

61.

Aktan-Collan K, Haukkala A, Mecklin JP, Uutela A, Kaariainen H (2001) Psychological consequences of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a prospective follow-up study. Int J Cancer 93:608–611PubMedCrossRef

62.

Ashida S, Koehly LM, Roberts JS, Chen CA, Hiraki S, Green RC (2009) Disclosing the disclosure: factors associated with communicating the results of genetic susceptibility testing for Alzheimer’s disease. J Health Commun 14:768–784PubMedCrossRef

63.

Meiser B, Collins V, Warren R, Gaff C, St John DJ, Young MA, Harrop K, Brown J, Halliday J (2004) Psychological impact of genetic testing for hereditary non-polyposis colorectal cancer. Clin Genet 66:502–511PubMedCrossRef

64.

Collins VR, Meiser B, Ukoumunne OC, Gaff C, St John DJ, Halliday JL (2007) The impact of predictive genetic testing for hereditary nonpolyposis colorectal cancer: three years after testing. Genet Med 9:290–297PubMedCrossRef

65.

Ho SM, Ho JW, Chan CL, Kwan K, Tsui YK (2003) Decisional consideration of hereditary colon cancer genetic test results among Hong Kong chinese adults. Cancer Epidemiol Biomarkers Prev 12:426–432PubMed

66.

Ho SM, Ho JW, Bonanno GA, Chu AT, Chan EM (2010) Hopefulness predicts resilience after hereditary colorectal cancer genetic testing: a prospective outcome trajectories study. BMC Cancer 10:279PubMedCrossRef

67.

Loader S, Shields C, Rowley PT (2005) Impact of genetic counseling and DNA testing on individuals with colorectal cancer with a positive family history: a population-based study. Genet Test 9:313–319PubMedCrossRef

68.

Aktan-Collan K, Kääriäinen H, Järvinen H, Peltomäki P, Pylvänäinen K, Mecklin JP, Haukkala A (2013) Psychosocial consequences of predictive genetic testing for lynch syndrome and associations to surveillance behaviour in a 7-year follow-up study. Fam Cancer. doi:10.1007/s10689-013-9628-9

69.

Collins V, Meiser B, Gaff C, St John DJ, Halliday J (2005) Screening and preventive behaviors one year after predictive genetic testing for hereditary nonpolyposis colorectal carcinoma. Cancer 104:273–281PubMedCrossRef

70.

Weissman SM, Bellcross C, Bittner CC, Freivogel ME, Haidle JL, Kaurah P, Leininger A, Palaniappan S, Steenblock K, Vu TM, Daniels MS (2011) Genetic counseling considerations in the evaluation of families for Lynch syndrome—a review. J Genet Couns 20:5–19PubMedCrossRef

71.

Berliner JL, Fay AM (2007) Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors. J Genet Couns 16:241–260PubMedCrossRef

72.

Sivell S, Elwyn G, Gaff CL, Clarke AJ, Iredale R, Shaw C, Dundon J, Thornton H, Edwards A (2008) How risk is perceived, constructed and interpreted by clients in clinical genetics, and the effects on decision making: systematic review. J Genet Couns 17:30–63PubMedCrossRef

73.

Aktan-Collan K, Haukkala A, Mecklin JP, Uutela A, Kaariainen H (2001) Comprehension of cancer risk one and 12 months after predictive genetic testing for hereditary non-polyposis colorectal cancer. J Med Genet 38:787–792PubMedCrossRef

74.

Hadley DW, Jenkins JF, Steinberg SM, Liewehr D, Moller S, Martin JC, Calzone KA, Soballe PW, Kirsch IR (2008) Perceptions of cancer risks and predictors of colon and endometrial cancer screening in women undergoing genetic testing for Lynch syndrome. J Clin Oncol 26:948–954PubMedCrossRef

75.

Bjorvatn C, Eide GE, Hanestad BR, Oyen N, Havik OE, Carlsson A, Berglund G (2007) Risk perception, worry and satisfaction related to genetic counseling for hereditary cancer. J Genet Couns 16:211–222PubMedCrossRef

76.

Domanska K, Carlsson C, Bendahl PO, Nilbert M (2009) Knowledge about hereditary nonpolyposis colorectal cancer; mutation carriers and physicians at equal levels. BMC Med Genet 10:30PubMedCrossRef

77.

Vos J, Menko F, Jansen AM, van Asperen CJ, Stiggelbout AM, Tibben A (2011) A whisper-game perspective on the family communication of DNA-test results: a retrospective study on the communication process of BRCA1/2-test results between proband and relatives. Fam Cancer 10:87–96PubMedCrossRef

78.

Palmquist AE, Koehly LM, Peterson SK, Shegog M, Vernon SW, Gritz ER (2010) “The cancer bond”: exploring the formation of cancer risk perception in families with Lynch syndrome. J Genet Couns 19:473–486PubMedCrossRef

79.

Werner-Lin A, Gardner DS (2009) Family illness narratives of inherited cancer risk: continuity and transformation. Fam Syst Health 27:201–212PubMedCrossRef

80.

Bartuma K, Nilbert M, Carlsson C (2012) Family perspectives in lynch syndrome becoming a family at risk, patterns of communication and influence on relations. Hered Cancer Clin Pract 10:6PubMedCrossRef

81.

Werner-Lin AV (2007) Danger zones: risk perceptions of young women from families with hereditary breast and ovarian cancer. Fam Process 46:335–349PubMedCrossRef

82.

Rao K (2009) Recent research in stress, coping and women’s health. Curr Opin Psychiatry 22:188–193PubMedCrossRef

83.

Petersen HV, Esplen MJ, Ladelund S, Bernstein I, Sunde L, Carlsson C, Nilbert M (2011) Limited impact on self-concept in individuals with Lynch syndrome; results from a national cohort study. Fam Cancer 10:633–639PubMedCrossRef

84.

Esplen MJ, Stuckless N, Hunter J, Liede A, Metcalfe K, Glendon G, Narod S, Butler K, Scott J, Irwin E (2009) The BRCA Self-Concept Scale: a new instrument to measure self-concept in BRCA1/2 mutation carriers. Psychooncology 18:1216–1229PubMedCrossRef

85.

Esplen MJ, Stuckless N, Gallinger S, Aronson M, Rothenmund H, Semotiuk K, Stokes J, Way C, Green J, Butler K, Petersen HV, Wong J (2011) Development and validation of an instrument to measure the impact of genetic testing on self-concept in Lynch syndrome. Clin Genet 80:415–423PubMedCrossRef

86.

Markus H, Nurius P (1986) Possible selves. Am Psychol 41:954–969CrossRef

87.

Markus H, Wurf E (1987) The dynamic self-concept: a social psychological perspective. Annu Rev Psychol 38:299–337CrossRef

88.

Baumeister R (1998) The self. In: Gilbert D, Fiske S, Lindzey G (eds) The handbook of social psychology. Oxford University Press, New York, pp 680–740

89.

Read CY, Perry DJ, Duffy ME (2005) Design and psychometric evaluation of the Psychological Adaptation to Genetic Information Scale. J Nurs Scholarsh 37:203–208PubMedCrossRef

90.

Schild S (1981) Social and psychological issues in genetic counseling. In: Thomas CC (ed) Genetic screening and counceling: a multidisciplinary perspective. Springfield, IL

91.

Petersen HV, Domanska K, Bendahl PO, Wong J, Carlsson C, Bernstein I, Esplen MJ, Nilbert M (2011) Validation of a self-concept scale for Lynch syndrome in different nationalities. J Genet Couns 20:308–313PubMedCrossRef

92.

d’Agincourt-Canning L (2001) Experiences of genetic risk: disclosure and the gendering of responsibility. Bioethics 15:231–247PubMedCrossRef

93.

Stein KF (1995) Schema model of the self-concept. Image J Nurs Sch 27:187–193PubMedCrossRef

94.

Rodriguez-Bigas MA, Vasen HF, O’Malley L, Rosenblatt MJ, Farrell C, Weber TK, Petrelli NJ (1998) Health, life, and disability insurance and hereditary nonpolyposis colorectal cancer. Am J Hum Genet 62:736–737PubMedCrossRef

95.

Norum J, Tranebjaerg L (2000) Health, life and disability insurance and hereditary risk for breast or colorectal cancer. Acta Oncol 39:189–193PubMedCrossRef

96.

Apse KA, Biesecker BB, Giardiello FM, Fuller BP, Bernhardt BA (2004) Perceptions of genetic discrimination among at-risk relatives of colorectal cancer patients. Genet Med 6:510–516PubMed

97.

Aktan-Collan K, Haukkala A, Kaariainen H (2001) Life and health insurance behaviour of individuals having undergone a predictive genetic testing programme for hereditary non-polyposis colorectal cancer. Commun Genet 4:219–224CrossRef

98.

Bleiker EM, Menko FH, Kluijt I, Taal BG, Gerritsma MA, Wever LD, Aaronson NK (2007) Colorectal cancer in the family: psychosocial distress and social issues in the years following genetic counselling. Hered Cancer Clin Pract 5:59–66PubMedCrossRef

99.

Barlow-Stewart K, Taylor SD, Treloar SA, Stranger M, Otlowski M (2009) Verification of consumers’ experiences and perceptions of genetic discrimination and its impact on utilization of genetic testing. Genet Med 11:193–201PubMedCrossRef

100.

Joly Y, Ngueng Feze I, Simard J (2013) Genetic discrimination and life insurance: a systematic review of the evidence. BMC Med 11:25PubMedCrossRef

101.

Bleiker EM, Hahn DE, Aaronson NK (2003) Psychosocial issues in cancer genetics—current status and future directions. Acta Oncol 42:276–286PubMedCrossRef

102.

Watson M, Lloyd S, Davidson J, Meyer L, Eeles R, Ebbs S, Murday V (1999) The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer. Br J Cancer 79:868–874PubMedCrossRef

103.

Thewes B, Meiser B, Tucker K, Schnieden V (2003) Screening for psychological distress and vulnerability factors in women at increased risk for breast cancer: a review of the literature. Psychol Health Med 8(3):289–303CrossRef

104.

Cella D, Hughes C, Peterman A, Chang CH, Peshkin BN, Schwartz MD, Wenzel L, Lemke A, Marcus AC, Lerman C (2002) A brief assessment of concerns associated with genetic testing for cancer: the multidimensional impact of cancer risk assessment (MICRA) questionnaire. Health Psychol 21:564–572PubMedCrossRef

105.

Esplen MJ, Cappelli M, Wong J, Bottorff JL, Hunter J, Carroll J, Dorval M, Wilson B, Allanson J, Semotiuk K, Aronson M, Bordeleau L, Charlemagne N, Meschino W (2013) Development and validation of a brief screening instrument for psychosocial risk associated with genetic testing: a pan-Canadian cohort study. BMJ Open. doi:10.1136/bmjopen-2012-002227

106.

Eijzenga W, Aaronson NK, Hahn DEE, Kluijt I, Bleiker EMA (2011) Development and testing of a screening questionnaire for psychosocial problems in onco-genetics. Psycho-Oncology 20:86

107.

Bleiker EMA, Eijzenga W, Aaronson NK, Hahn DEE, Sidharta GN, Kluijt I, Ausems MGEM (2013) The signal trial: screening for psychosocial problems in cancer genetic counseling. Fam Cancer 12:S19CrossRef

108.

Hadley DW, Jenkins JF, Dimond E, de Carvalho M, Kirsch I, Palmer CG (2004) Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol 22:39–44PubMedCrossRef

109.

Stoffel EM, Mercado RC, Kohlmann W, Ford B, Grover S, Conrad P, Blanco A, Shannon KM, Powell M, Chung DC, Terdiman J, Gruber SB, Syngal S (2010) Prevalence and predictors of appropriate colorectal cancer surveillance in Lynch syndrome. Am J Gastroenterol 105:1851–1860PubMedCrossRef

110.

111.

Ketabi Z, Mosgaard BJ, Gerdes AM, Ladelund S, Bernstein IT (2012) Awareness of endometrial cancer risk and compliance with screening in hereditary nonpolyposis colorectal cancer. Obstet Gynecol 120:1005–1012PubMed

112.

113.

Schmeler KM, Lynch HT, Chen LM, Munsell MF, Soliman PT, Clark MB, Daniels MS, White KG, Boyd-Rogers SG, Conrad PG, Yang KY, Rubin MM, Sun CC, Slomovitz BM, Gershenson DM, Lu KH (2006) Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 354:261–269PubMedCrossRef

114.

Burn J, Gerdes AM, Macrae F, Mecklin JP, Moeslein G, Olschwang S, Eccles D, Evans DG, Maher ER, Bertario L, Bisgaard ML, Dunlop MG, Ho JW, Hodgson SV, Lindblom A, Lubinski J, Morrison PJ, Murday V, Ramesar R, Side L, Scott RJ, Thomas HJ, Vasen HF, Barker G, Crawford G, Elliott F, Movahedi M, Pylvanainen K, Wijnen JT, Fodde R, Lynch HT, Mathers JC, Bishop DT (2011) Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet 378:2081–2087PubMedCrossRef

115.

Ishii N, Arai M, Koyama Y, Ueno M, Yamaguchi T, Kazuma K, Muto T (2011) Factors affecting encouragement of relatives among families with Lynch syndrome to seek medical assessment. Fam Cancer 10:649–654PubMedCrossRef

116.

Dancyger C, Wiseman M, Jacobs C, Smith JA, Wallace M, Michie S (2011) Communicating BRCA1/2 genetic test results within the family: a qualitative analysis. Psychol Health 26:1018–1035PubMedCrossRef

117.

Mesters I, Ausems M, Eichhorn S, Vasen H (2005) Informing one’s family about genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a retrospective exploratory study. Fam Cancer 4:163–167PubMedCrossRef

118.

Seymour KC, Addington-Hall J, Lucassen AM, Foster CL (2010) What facilitates or impedes family communication following genetic testing for cancer risk? A systematic review and meta-synthesis of primary qualitative research. J Genet Couns 19:330–342CrossRef

119.

Morris BA, Hadley DW, Koehly LM (2013) The role of religious and existential well-being in families with lynch syndrome: prevention, family communication, and psychosocial adjustment. J Genet Couns. doi:10.1007/s10897-013-9571-9

120.

Green J, Richards M, Murton F, Statham H, Hallowell N (1997) Family communication and genetic counseling: the case of hereditary breast and ovarian cancer. J Genet Couns 6:45–60CrossRef

121.

Gaff CL, Collins V, Symes T, Halliday J (2005) Facilitating family communication about predictive genetic testing: probands’ perceptions. J Genet Couns 14:133–140PubMedCrossRef

122.

Ersig AL, Williams JK, Hadley DW, Koehly LM (2009) Communication, encouragement, and cancer screening in families with and without mutations for hereditary nonpolyposis colorectal cancer: a pilot study. Genet Med 11:728–734PubMedCrossRef

123.

Coyle YM (2009) Lifestyle, genes, and cancer. Methods Mol Biol 472:25–56PubMedCrossRef

124.

Campbell PT, Curtin K, Ulrich CM, Samowitz WS, Bigler J, Velicer CM, Caan B, Potter JD, Slattery ML (2009) Mismatch repair polymorphisms and risk of colon cancer, tumour microsatellite instability and interactions with lifestyle factors. Gut 58:661–667PubMedCrossRef

125.

Palmquist AE, Upton R, Lee S, Panter AT, Hadley DW, Koehly LM (2011) Beliefs about cancer and diet among those considering genetic testing for colon cancer. J Nutr Educ Behav 43:150–156PubMedCrossRef

126.

Underhill ML, Lally RM, Kiviniemi MT, Murekeyisoni C, Dickerson SS (2012) Living my family’s story: identifying the lived experience in healthy women at risk for hereditary breast cancer. Cancer Nurs 35(6):493–504

127.

Lemon SC, Zapka JG, Clemow L (2004) Health behavior change among women with recent familial diagnosis of breast cancer. Prev Med 39:253–262PubMedCrossRef

128.

Audrain J, Schwartz M, Herrera J, Goldman P, Bush A (2001) Physical activity in first-degree relatives of breast cancer patients. J Behav Med 24:587–603PubMedCrossRef

129.

Madlensky L, Vierkant RA, Vachon CM, Pankratz VS, Cerhan JR, Vadaparampil ST, Sellers TA (2005) Preventive health behaviors and familial breast cancer. Cancer Epidemiol Biomarkers Prev 14:2340–2345PubMedCrossRef

130.

131.

Burton AM, Peterson SK, Marani SK, Vernon SW, Amos CI, Frazier ML, Lynch PM, Gritz ER (2010) Health and lifestyle behaviors among persons at risk of Lynch syndrome. Cancer Causes Control 21:513–521PubMedCrossRef

132.

Simpson JL (2010) Preimplantation genetic diagnosis at 20 years. Prenat Diagn 30:682–695PubMedCrossRef

133.

Avigad S, Peleg D, Barel D, Benyaminy H, Ben Baruch N, Taub E, Shohat M, Goshen Y, Cohen IJ, Yaniv I, Zaizov R (2004) Prenatal diagnosis in Li-Fraumeni syndrome. J Pediatr Hematol Oncol 26:541–545PubMedCrossRef

134.

Ao A, Wells D, Handyside AH, Winston RM, Delhanty JD (1998) Preimplantation genetic diagnosis of inherited cancer: familial adenomatous polyposis coli. J Assist Reprod Genet 15:140–144PubMedCrossRef

135.

Dommering CJ, van den Heuvel MR, Moll AC, Imhof SM, Meijers-Heijboer H, Henneman L (2010) Reproductive decision-making: a qualitative study among couples at increased risk of having a child with retinoblastoma. Clin Genet 78:334–341PubMedCrossRef

136.

Huang SM, Tao BL, Tzeng CC, Liu HT, Wang WP (1997) Prenatal molecular diagnosis of RET proto-oncogene mutation in multiple endocrine neoplasia type 2A. J Formos Med Assoc 96:542–544PubMed

137.

Rechitsky S, Verlinsky O, Chistokhina A, Sharapova T, Ozen S, Masciangelo C, Kuliev A, Verlinsky Y (2002) Preimplantation genetic diagnosis for cancer predisposition. Reprod Biomed Online 5:148–155PubMedCrossRef

138.

Offit K, Kohut K, Clagett B, Wadsworth EA, Lafaro KJ, Cummings S, White M, Sagi M, Bernstein D, Davis JG (2006) Cancer genetic testing and assisted reproduction. J Clin Oncol 24:4775–4782PubMedCrossRef

139.

HFEA. Authority decision on the use of PGD for lower penetrance, later onset inherited conditions. 2006. (Unpublished Work)

140.

Staton AD, Kurian AW, Cobb K, Mills MA, Ford JM (2008) Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers. Fam Cancer 7:179–186PubMedCrossRef

141.

Lammens C, Bleiker E, Aaronson N, Vriends A, Ausems M, Jansweijer M, Wagner A, Sijmons R, van den Ouweland A, van der Luijt R, Spruijt L, Gomez Garcia E, Ruijs M, Verhoef S (2009) Attitude towards pre-implantation genetic diagnosis for hereditary cancer. Fam Cancer 8:457–464PubMedCrossRef

142.

Marteau T, Michie S, Drake H, Bobrow M (1995) Public attitudes towards the selection of desirable characteristics in children. J Med Genet 32:796–798PubMedCrossRef

143.

Genetics and Public Policy Center. Americans deeply divided about use of genetic technologies in reproduction. 2004. Princeton Survey Research Associates

144.

Daina G, Ramos L, Obradors A, Rius M, Martinez-Pasarell O, Polo A, Del Rey J, Obradors J, Benet J, Navarro J (2012) First successful double-factor PGD for Lynch syndrome: monogenic analysis and comprehensive aneuploidy screening. Clin Genet. doi:10.1111/cge.12025

145.

Clancy T (2010) A clinical perspective on ethical arguments around prenatal diagnosis and preimplantation genetic diagnosis for later onset inherited cancer predispositions. Fam Cancer 9:9–14PubMedCrossRef

146.

Meister U, Finck C, Stobel-Richter Y, Schmutzer G, Brahler E (2005) Knowledge and attitudes towards preimplantation genetic diagnosis in Germany. Hum Reprod 20:231–238PubMedCrossRef

147.

Vadaparampil ST, Quinn GP, Knapp C, Malo TL, Friedman S (2009) Factors associated with preimplantation genetic diagnosis acceptance among women concerned about hereditary breast and ovarian cancer. Genet Med 11:757–765PubMedCrossRef

148.

Douma KF, Aaronson NK, Vasen HF, Verhoef S, Gundy CM, Bleiker EM (2010) Attitudes toward genetic testing in childhood and reproductive decision-making for familial adenomatous polyposis. Eur J Hum Genet 18:186–193PubMedCrossRef

149.

Patenaude AF. Living with Li-Fraumeni syndrome: psychological aspects. Invited talk given to NIH meeting on Li-Fraumeni syndrome. 2010. Bethesda, Maryland

150.

Rubinstein WS, Weissman SM (2008) Managing hereditary gastrointestinal cancer syndromes: the partnership between genetic counselors and gastroenterologists. Nat Clin Pract Gastroenterol Hepatol 5:569–582PubMedCrossRef

151.

Shiloh S, Koehly L, Jenkins J, Martin J, Hadley D (2008) Monitoring coping style moderates emotional reactions to genetic testing for hereditary nonpolyposis colorectal cancer: a longitudinal study. Psycho-Oncology 17:746–755PubMedCrossRef

152.

Carlsson C, Nilbert M (2007) Living with hereditary non-polyposis colorectal cancer; experiences from and impact of genetic testing. J Genet Couns 16:811–820PubMedCrossRef

153.

Wham D, Vu T, Chan-Smutko G, Kobelka C, Urbauer D, Heald B (2010) Assessment of clinical practices among cancer genetic counselors. Fam Cancer 9:459–468PubMedCrossRef

154.

Brain K, Sivell S, Bennert K, Howell L, France L, Jordan S, Rogers MT, Gray J, Sampson J (2005) An exploratory comparison of genetic counselling protocols for HNPCC predictive testing. Clin Genet 68:255–261PubMedCrossRef

155.

Roberts ME, Riegert-Johnson DL, Thomas BC (2011) Self diagnosis of Lynch syndrome using direct to consumer genetic testing: a case study. J Genet Couns 20:327–329PubMedCrossRef

156.

Vig HS, Wang C (2012) The evolution of personalized cancer genetic counseling in the era of personalized medicine. Fam Cancer 11:539–544PubMedCrossRef

157.

Vos J, Oosterwijk JC, Gomez-Garcia E, Menko FH, Collee MJ, van Asperen CJ, Jansen AM, Stiggelbout AM, Tibben A (2012) Exploring the short-term impact of DNA-testing in breast cancer patients: the counselees’ perception matters, but the actual BRCA1/2 result does not. Patient Educ Couns 86:239–251PubMedCrossRef

158.

Hampel H, de la Chapelle A (2011) The search for unaffected individuals with Lynch syndrome: do the ends justify the means? Cancer Prev Res (Phila) 4:1–5CrossRef

159.

Ramsey S, Blough D, McDermott C, Clarke L, Bennett R, Burke W, Newcomb P (2010) Will knowledge of gene-based colorectal cancer disease risk influence quality of life and screening behavior? Findings from a population-based study. Public Health Genomics 13:1–12PubMedCrossRef

160.

Nusbaum R, Leventhal KG, Hooker GW, Peshkin BN, Butrick M, Salehizadeh Y, Tuong W, Eggly S, Mathew J, Goerlitz D, Shields PG, Schwartz MD, Graves KD (2013) Translational genomic research: protocol development and initial outcomes following SNP testing for colon cancer risk. Transl Behav Med 3:17–29PubMedCrossRef

161.

Graves KD, Leventhal KG, Nusbaum R, Salehizadeh Y, Hooker GW, Peshkin BN, Butrick M, Tuong W, Mathew J, Goerlitz D, Fishman MB, Shields PG, Schwartz MD (2013) Behavioral and psychosocial responses to genomic testing for colorectal cancer risk. Genomics. doi:10.1016/j.ygeno.2013.04.002

162.

Saleh M, Barlow-Stewart K, Meiser B, Tucker K, Eisenbruch M, Kirk J (2012) Knowledge, attitudes and beliefs of Arabic-Australians concerning cancer. Psycho-Oncology 21:195–202PubMedCrossRef

163.

Eisenbruch M, Yeo SS, Meiser B, Goldstein D, Tucker K, Barlow-Stewart K (2004) Optimising clinical practice in cancer genetics with cultural competence: lessons to be learned from ethnographic research with Chinese-Australians. Soc Sci Med 59:235–248PubMedCrossRef

164.

Patenaude AF, Julian-Reynier C (2008) Cancer genetic testing: current and emerging issues. Psycho-Oncology 17:733–736PubMedCrossRef

165.

Clarke S, Butler K, Esplen MJ (2008) The phases of disclosing BRCA1/2 genetic information to offspring. Psycho-Oncology 17:797–803PubMedCrossRef

Titel: 100 years lynch syndrome: what have we learned about psychosocial issues?
verfasst von: Eveline M. A. Bleiker
Mary Jane Esplen
Bettina Meiser
Helle Vendel Petersen
Andrea Farkas Patenaude
Publikationsdatum: 01.06.2013
Verlag: Springer Netherlands
Erschienen in: Familial Cancer / Ausgabe 2/2013
Print ISSN: 1389-9600
Elektronische ISSN: 1573-7292
DOI: https://doi.org/10.1007/s10689-013-9653-8

Springer Medizin

100 years lynch syndrome: what have we learned about psychosocial issues?

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2013

The role of epigenetics in Lynch syndrome

The InSiGHT database: utilizing 100 years of insights into Lynch Syndrome

Surveillance for urinary tract cancer in Lynch syndrome

The History of Lynch Syndrome

Cancer risk in Lynch Syndrome

Foreword for “100 years of Lynch syndrome”

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie